Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of NLRP3 inflammasome

International Journal of Cardiology

Volumn 160, Issue 1, 2012, Pages 72-73

  He, Jia ^a   Yang, Yang ^a   Peng, Dao Quan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Coronary heart disease (CHD); Gout; Monosodium urate (MSU) crystals; NLRP3 inflammasome

Indexed keywords

CRYOPYRIN; INFLAMMASOME; URATE;

CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; GOUT; HUMAN; HYPERURICEMIA; ISCHEMIC HEART DISEASE; LETTER; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THORAX PAIN;

EID: 84865627788     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.083     Document Type: Article

References (17)

1. H.K. Choi, and G. Curhan Independent impact of gout on mortality and risk for coronary heart disease Circulation 116 2007 894 900
2. E. Krishnan, K. Svendsen, J.D. Neaton, G. Grandits, and L.H. Kuller Long-term cardiovascular mortality among middle-aged men with gout Arch Intern Med 168 2008 1104 1110
3. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, and D.A. Albert Hyperuricemia and coronary heart disease: a systematic review and meta-analysis Arthritis Care Res (Hoboken) 62 2010 170 180
4. B.F. Culleton, M.G. Larson, W.B. Kannel, and D. Levy Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 131 1999 7 13
5. D.I. Feig, D.H. Kang, and R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
6. M.W. So, S.G. Lee, Y.G. Kim, C.K. Lee, and B. Yoo Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study Scand J Rheumatol 40 2011 444 447
7. D.J. McCarty Gout without hyperuricemia JAMA 271 1994 302 303
8. N. Schlesinger, D.G. Baker, and H.R. Schumacher Jr. Serum urate during bouts of acute gouty arthritis J Rheumatol 24 1997 2265 2266
9. H.R. Schumacher Jr., J.A. Boice, and D.I. Daikh Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis BMJ 324 2002 1488 1492
10. B.R. Rubin, R. Burton, and S. Navarra Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial Arthritis Rheum 50 2004 598 606
11. N. Schlesinger, J.M. Norquist, and D.J. Watson Serum urate during acute gout J Rheumatol 36 2009 1287 1289
12. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
13. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
14. A. Bertazzo, L. Punzi, and N. Bertazzolo Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines Adv Exp Med Biol 467 1999 565 570
15. P. Duewell, H. Kono, and K.J. Rayner NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
16. T. Inokuchi, Y. Moriwaki, and H. Tsutsui Plasma interleukin (IL)-18 (interferon-gamma-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18 Cytokine 33 2006 21 27
17. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605